Literature DB >> 25514343

Is platelet-rich plasma injection an effective choice in cases of non-union?

F Say1, E Türkeli, M Bülbül.   

Abstract

PURPOSE OF THE STUDY: By the expression of several growth factors from activated thrombocytes, the application of Platelet Rich Plasma (PRP) stimulates angiogenesis and regeneration thus stimulating recovery through cell differentiation. This study aimed to evaluate the effects of PRP injection on patients who had undergone surgery for fracture and in whom delayed union or nonunion had been determined.
MATERIAL AND METHODS: The study comprised 20 patients (male 17, female 3; median age 33.5 range 15-77) who had undergone lower extremity fracture surgery and were diagnosed with aseptic delayed union (8 patients) or non-union (12 patients). Blood taken from the patients was centrifuged to separate PRP, which was then activated by calcium chloride. The prepared PRP was injected into the fracture line under fluoroscopy guidance for totally three times once a week. The application of PRP was made at median 6 (range 6-8) months after fracture surgery. All patients were followed-up with clinical examinations and radiographs over a median period of 11 (range 8-12) months.
RESULTS: Fracture union was achieved in six patients at median 15 (range 8-24) weeks. There was non-union of the fracture in eleven patients during the follow-up period and these patients underwent revision surgery. Sufficient union was not determined radiologically and clinically in three patients. Fracture union was achieved in six of eight patients in the delayed union group. There was no patient in the non-union group with fracture union.
CONCLUSIONS: Fracture healing is a process affected by many factors. Although PRP has been reported in literature to be a biological treatment which increases healing, adequate healing was not determined in the treatment of non-union with PRP injection. However, in selected patients determined with delayed union, PRP injection can be recommended in non-surgical treatment.

Entities:  

Mesh:

Year:  2014        PMID: 25514343

Source DB:  PubMed          Journal:  Acta Chir Orthop Traumatol Cech        ISSN: 0001-5415            Impact factor:   0.531


  7 in total

Review 1.  Platelet-rich plasma for the treatment of bone defects: from pre-clinical rational to evidence in the clinical practice. A systematic review.

Authors:  Alice Roffi; Berardo Di Matteo; Gopal Shankar Krishnakumar; Elizaveta Kon; Giuseppe Filardo
Journal:  Int Orthop       Date:  2016-11-26       Impact factor: 3.075

2.  Investigating the Effect of Intra-articular Platelet-Rich Plasma Injection on Union: Pain and Function Improvement in Patients with Scaphoid Fracture.

Authors:  Hamid Namazi; Toomaj Kayedi
Journal:  J Hand Microsurg       Date:  2016-11-30

3.  Role of autologous platelet-rich plasma in treatment of long-bone nonunions: a prospective study.

Authors:  R Malhotra; V Kumar; B Garg; R Singh; V Jain; P Coshic; K Chatterjee
Journal:  Musculoskelet Surg       Date:  2015-07-21

Review 4.  The role of Platelet Rich Plasma and other orthobiologics in bone healing and fracture management: A systematic review.

Authors:  M S Jamal; E T Hurley; H Asad; A Asad; T Taneja
Journal:  J Clin Orthop Trauma       Date:  2022-01-04

5.  Effects of Platelet Rich Plasma on Healing Rate of Long Bone Non-union Fractures: A Randomized Double-Blind Placebo Controlled Clinical Trial.

Authors:  Fariborz Ghaffarpasand; Mostafa Shahrezaei; Maryam Dehghankhalili
Journal:  Bull Emerg Trauma       Date:  2016-07

6.  Clinical Effectiveness of Platelet-Rich Plasma for Long-Bone Delayed Union and Nonunion: A Systematic Review and Meta-Analysis.

Authors:  Shang Li; Fei Xing; Rong Luo; Ming Liu
Journal:  Front Med (Lausanne)       Date:  2022-01-25

7.  Platelet-Rich Plasma Combined With Autologous Grafting in the Treatment of Long Bone Delayed Union or Non-union: A Meta-Analysis.

Authors:  Weijun An; Peng Ye; Tao Zhu; Zhizhong Li; Jianbin Sun
Journal:  Front Surg       Date:  2021-06-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.